Sept 18 (Reuters) - President Donald Trump plans to announce on Friday that the administration's Medicaid most-favored-nation ...

Sept 18 (Reuters) - The Donald Trump administration is set to announce on Friday that all 50 states would see ...

BOGOTA, Sept 16 (Reuters) - The United States has ⁠removed ⁠Venezuela from its list ⁠of countries which have failed to ...

Europe’s patients could face longer waits for some new medicines as US efforts to drive down drug prices risk encouraging ...

First teased in June and formally announced Tuesday as part of “Operation Trialblazer,” the program will partner drugmakers ...

President Donald Trump said Medicaid programs in 50 states will get "most favored nation" pricing, part of his administration ...

Trump says all 50 states have joined his Medicaid drug-pricing plan as Democrats seek to keep healthcare central in the ...

Key points of this articleOn August 26, 2026, the three pharmaceutical associations (Japan Pharmaceutical Manufacturers ...

Xenon Pharmaceuticals stock sinks as the company halts enrollment of new patients in a key trial. Here’s how you should play XENE shares at current levels.

Consumer health company Haleon has achieved growing sales of products to counter side-effects of weight-loss drugs in the ...

Ahead of the midterm elections, the president said that all states had opted in to an effort to align Medicaid’s prices for ...

The US FDA has approved Eli Lilly's drug combination to treat adults with a type of advanced breast cancer that has spread to ...